Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Vertex-Affinia partnership: expanding the gene therapy toolkit

Building on the success of its gene-targeted cystic fibrosis therapies, Vertex has begun to expand into new disease areas that would benefit from a similar gene therapy approach. To this end, it has begun to develop a toolkit of technology to support drug development in new spaces, including DMD and DM1, bringing on-board AAV capsid-focused Affinia.

Close
Close
Close

Go Top